Moore Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 500 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 540 |
|
|
2021
Q2 | – | Sell |
-30,912
| Closed | -$6.64M | – | 893 |
|
|
2021
Q1 | $6.64M | Sell |
30,912
-19,951
| -39% | -$4.29M | 0.08% | 194 |
|
|
2020
Q4 | $12M | Buy |
+50,863
| New | +$12M | 0.13% | 94 |
|
|
2017
Q4 | – | Sell |
-25,000
| Closed | -$3.8M | – | 282 |
|
|
2017
Q3 | $3.8M | Buy |
+25,000
| New | +$3.8M | 0.07% | 120 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 324 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 341 |
|
|
2015
Q3 | – | Sell |
-80,000
| Closed | -$9.88M | – | 379 |
|
|
2015
Q2 | $9.88M | Sell |
80,000
-17,500
| -18% | -$2.16M | 0.21% | 78 |
|
|
2015
Q1 | $11.5M | Buy |
+97,500
| New | +$11.5M | 0.25% | 67 |
|